This is a routine administrative filing correcting a missing Say-on-Pay proposal. No market-moving information. Monitor the June 26 meeting outcome for any unexpected opposition to director elections or compensation, though none are anticipated given management's unified recommendation.
Price Chart
Executive Summary
vTv Therapeutics filed a DEFA14A to correct an inadvertent omission from its 2026 proxy statement, adding an advisory vote (Say-on-Pay) on executive compensation as Proposal 3. The annual meeting was adjourned from June 10 to June 26, 2026, without transacting any business, to allow shareholders time to review the new proposal. This is a routine administrative correction with no material financial or strategic impact.
Key Facts
- Original proxy statement (filed April 28, 2026) inadvertently omitted Proposal 3 for an advisory vote on executive compensation.
- Annual meeting convened June 10, 2026 was adjourned immediately without any business transacted.
- Adjourned meeting will resume June 26, 2026 at 11:00 AM ET via virtual webcast.
- Record date remains April 14, 2026; voting deadline extended to June 24, 2026.
- Board recommends FOR all three proposals: director election, auditor ratification, and Say-on-Pay.
- Proposal 1 (director election) and Proposal 3 (Say-on-Pay) are non-routine (broker discretionary voting prohibited).
Financial Impact
No financial figures disclosed; purely procedural proxy correction.
Risk Factors
- No material risks identified; routine filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-265834 |
| Document: 0001193125-26-265834-index-headers.html | 0001193125-26-265834 |
| Document: 0001193125-26-265834-index.html | 0001193125-26-265834 |
| Document: 0001193125-26-265834.txt | 0001193125-26-265834 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 10, 2026 16w ago | DEFA14A | $31.59 $33.35 | ▲ +5.57% | ▲ +1.18% | $31.34 (−0.79%) |
May 8, 2026 20w ago | Press Release | $30.46 $34.39 | ▲ +12.90% | ▲ +8.51% | $31.34 (+2.89%) |
Mar 10, 2026 29w ago | Press Release | $35.10 $32.94 | ▼ −6.15% | ▼ −17.68% | $31.34 (−10.71%) |
Feb 26, 2026 31w ago | 8-K | $39.32 $35.50 | ▼ −9.72% | ▼ −17.47% | $31.34 (−20.30%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access